首页 | 本学科首页   官方微博 | 高级检索  
     

盐酸托烷司琼国家一级化学纯度标准物质研究
引用本文:邢逞,张丽,杨世颖,胡帆,杜慧,吕扬. 盐酸托烷司琼国家一级化学纯度标准物质研究[J]. 中国现代应用药学, 2018, 35(7): 953-958
作者姓名:邢逞  张丽  杨世颖  胡帆  杜慧  吕扬
作者单位:北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050,北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050,北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050,北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050,北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050,北京协和医学院, 中国医学科学院药物研究所药物晶型研究中心, 晶型药物北京市重点实验室, 北京 100050
基金项目:国家重点研发计划项目(2016YFC1000900);中国医学科学院医学与健康科技创新工程项目(2017-I2M-1-10)
摘    要:目的 通过准确可靠的定值方法及不确定度分析研究,研制具有可溯源和量值传递功能的盐酸托烷司琼国家一级化学纯度标准物质。方法 以5-HT3受体拮抗剂盐酸托烷司琼为研究对象,根据我国计量法和一级标准物质研制技术规范与相关技术文件要求,采用HPLC对盐酸托烷司琼纯度标准物质进行均匀性和稳定性检验;采用HPLC和差示扫描量热法2种不同原理方法联合定值,并完成不确定度评估。结果 研制的盐酸托烷司琼纯度标准物质具有良好的均匀性和稳定性,纯度标准值为99.7%,不确定度为0.4%(k=2)。结论 研制的盐酸托烷司琼为国家一级标准物质(GBW09494)。该研究可实现相关成分的量值溯源及量值传递,同时为我国药品的标准化和现代化提供了重要的标准物质和标准分析方法。

关 键 词:盐酸托烷司琼  纯度标准物质  高效液相色谱法  差示扫描量热法
收稿时间:2017-10-27
修稿时间:2018-01-09

Study of National Primary Purity Certified Reference Material of Tropisetron Hydrochloride
XING Cheng,ZHANG Li,YANG Shiying,HU Fan,DU Hui and LYU Yang. Study of National Primary Purity Certified Reference Material of Tropisetron Hydrochloride[J]. The Chinese Journal of Modern Applied Pharmacy, 2018, 35(7): 953-958
Authors:XING Cheng  ZHANG Li  YANG Shiying  HU Fan  DU Hui  LYU Yang
Affiliation:Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China,Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China,Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China,Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China,Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China and Peking Union Medical College, Beijing City Key Laboratory of Pharmaceutical Polymorph, Rearch Centre of Polymorphic Drugs, Institute of Materia Medica & Chinese Academy of Medical Sciences, Beijing 100050, China
Abstract:OBJECTIVE To develop the national primary purity certified reference material(CRM) of tropisetron hydrochloride which has measurement traceability and value transfer function through establishing accurate, reliable analytical method of valuation and uncertainty. METHODS The 5-HT3 receptor antagonist tropisetron hydrochloride was used as the study object. The homogeneity and the stability were checked by HPLC. The purity of tropisetron hydrochloride CRM was certified by the joint certification including HPLC and differential scanning calorimetry, and the uncertainty was carefully evaluated on the basis of Technical Norm of Primary Reference Material and related documents requirements. RESULTS Tropisetron hydrochloride CRM showed satisfactory homogeneity and stability. The purity of tropisetron hydrochloride CRM was 99.7% and the uncertainty was 0.4%(k=2). CONCLUSION The national primary CRM of tropisetron hydrochloride developed has been assigned as a grade primary reference material(GBW09494). The study enables measurement traceability and value transfer of related components, as well as provides important reference material and standard analysis methods for the standardization and modernization of medicines.
Keywords:tropisetron hydrochloride  purity certified reference material  HPLC  differential scanning calorimetry
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号